The Centre for Aging + Brain Health Innovation (CABHI), led by Baycrest, today announced support for the development and validation testing of 15 new innovations in aging and brain health – driving forward opportunities to bring to market promising products and services aimed at improving the quality of life for those affected by dementia and their caregivers.
Led by companies and researchers worldwide, these innovations have received support through CABHI’s programs, including the Researcher-Clinician Partnership Program (RCP2); the Industry Innovation Partnership Program (I2P2); and the Strategic Opportunity Fund (SOF). CABHI’s support for these innovations provides access to real-world settings for validation testing, generating evidence that will help innovations attract further investment for scale.
Among the supported projects:
- A digital therapeutic device that picks up on the voice and gestures of an older adult experiencing delirium and helps calm them using engaging computer-generated imagery
- A cognitive behaviour therapy-based wellness tool that promotes resilience and brain health by using goal-setting techniques
- A language retention app to reduce caregiver stress and promote aging in place related to dementia in Indigenous populations
“CABHI’s programs and services empower people to advance aging and brain health innovation,” said Dr. Allison Sekuler, Managing Director for CABHI and Vice-President, Research at Baycrest and Sandra A. Rotman Chair in Cognitive Neuroscience. “We’re looking forward to seeing these projects positively impact the senior’s care and the longevity sector — in Ontario, across Canada, and around the world. We’re excited CABHI can play part in contributing to the innovation ecosystem, and, more importantly, to improving the lives of those with dementia and their caregivers.”
